VITASPRING BIOMEDICAL CO., LTD. (VSBC) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

VITASPRING BIOMEDICAL CO., LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.01 per share for the 12-month period ending 2026-01-31, per its 10-K filed 2026-06-17.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-06-17

• VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-04-30 was $0.01, a 0.00% change year-over-year.
• VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-04-30 was $0.01.
• VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2026 was $0.01, a 0.00% change from fiscal 2025.
• VITASPRING BIOMEDICAL CO., LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $0.01.